Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Fintel reports that on December 18, 2025, JP Morgan downgraded their outlook for SmartStop Self Storage REIT (NYSE:SMA) from ...

Spinal muscular atrophy (SMA) is a genetic neuromuscular disease affecting specialized nerve cells that control voluntary muscle movement, according to the Muscular Dystrophy Association (MDA). It can ...

Significant unmet needs in SMA management include therapy access, fatigue, reproductive health, and emerging phenotypes in older patients. Intrathecal gene therapy offers potential for older SMA ...

Adult-onset spinal muscular atrophy (SMA) is a rare neuromuscular disorder that primarily affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy. SMA is part of a group ...

Real-world analyses in SMA provide crucial data for long-term comparisons, focusing on SMA types 2 and 3. The HFMSE is a reliable tool for assessing motor abilities and disease progression in SMA2 and ...

The risk of scoliosis was largely related to what type of SMA a patient had, with those with type III having the lowest risk and those with type II developing scoliosis at a later age than those with ...

After stellar financial results in 2023, SMA Solar shares are down almost 90% from their peak in June 2023 and 80% YTD. The company achieved record revenue and profit quadrupled in 2023, but guidance ...

Under the motto 35 Years of SMA A Vision Becomes Reality, SMA Solar Technology AG (SMA) celebrated its 35th anniversary today with numerous guests from the worlds of business, academia and politics.

MONDAY, Aug. 11, 2025 (HealthDay News) — Spinal muscular atrophy (SMA) is a genetic neuromuscular disease affecting specialized nerve cells that control voluntary muscle movement, according to the ...